Oil Keeps Climbing After Hitting Multi‑Week Highs As US‑China Trade Talks Spark Demand Hopes Brent crude futures rose 0.3% at $67.22 per barrel, while West Texas Intermediate crude futures were up 0.2% at $65.43 per barrel, as of 1.04 am ET.
Trump Account Promises $1000 For Every Kid — But Not Everyone Thinks Its The Smartest Idea Out There Trump's tax-and-spending bill includes $1,000 Trump Account for every US baby born between 2025-2029. Critics question design and cost.
Robinhood Stock Declines After Failing To Make It To S&P 500 Index During Quarterly Rebalancing Investor hopes were high after Bank of America said last week that HOOD stock is a prime candidate to join the S&P 500.
Self-Driving Cars May Slash Insurance Costs 50% By 2040, Challenge Traditional Insurers: Goldman Sachs Goldman Sachs says autonomous vehicles could slash U.S. auto insurance costs, shifting risk toward product liability and disrupting the $430B market.
Starbucks Cuts Beverage Prices In China To Attract Customers The American coffee chain faces a challenge in the country from emerging local chains such as Luckin Coffee and Cotti Coffee.
Foreign Investors Pull $37 Billion From US Stocks In May—Largest Monthly Exit In A Year: Exodus Amid Market Recovery, 90-Day Tariff Pause New figures from U.S. equity markets indicate a troubling trend, as foreign investors pull back amid mounting uncertainties and persistent volatility over the past two months.
Benzinga Bulls And Bears: Spotify, Applied Digital, DocuSign — And Tesla Swings On Musk-Trump Feud Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.
Goldman Sachs Bullish On Branded Drug Upside At Teva: What About Viatris? Goldman Sachs initiates Teva, Viatris, and Amneal, highlighting branded growth and pipeline strength, but one company's unclear outlook.
Omada Health Stock Shoots Up 42% In Nasdaq Debut, Breaches $26 Mark For the quarter ended March 2025, the firm’s revenue shot up 57% year-over-year to $55 million.
Omada Health Prices $150M IPO In-Line With Estimated Range Omada Health (OMDA) priced its IPO at $19 per share, midpoint of the previously estimated price range of $18.00 and $20.00 per share
BlackRock Stock In Spotlight As Investment Manager Plans Fresh Job Cuts: Retail's Bearish In April, BlackRock stated that its employee compensation and benefits expense increased by 7% in the first quarter following acquisitions.
Goldman Sachs Pares Risk Post Trump's Liberation Day Tariffs: President John Waldron Calls It A 'Sensible' Move Waldron said in a podcast that Goldman Sachs is absorbing a “lot of risk” from its clients, but wherever possible, it is paring risks and staying “a bit closer to home.”
Think 5% Yields Will Crush Stock Market? Goldman Sachs Says Think Again Goldman Sachs challenges the view that 5% yields on U.S. Treasuries are a breaking point for stocks, citing no consistent correlation.
3 Warren Buffett Stocks to Buy Hand Over Fist in June Several of the Oracle of Omaha's longtime favorites would be at home in most investors' portfolios.
Yum! Brands Tipped For 16% Upside As Analyst Points To Strong Unit Growth, AI Investment Goldman Sachs analyst Christine Cho upgrades Yum! Brands, Inc. from Neutral to Buy with a $167 price forecast. Company shows strong growth and resilience.
Bitcoin Hedge Theory Meets a Harsh Boardroom Reality Is Bitcoin finally ready to serve as a hedge against dollar volatility? Meta shareholders just delivered a crushing verdict on that idea, amplifying an earlier Microsoft vote.
Microsoft Stock Near Peak, Pullback Seen as Opportunity Microsoft stock is near its all-time high but may face short-term pullback on headline news and lower summer volume; investors should embrace that opportunity
